---

$0.01

+0.0057 ( +247.83% ) 2,147.5M

Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics the way bodies naturally induce tolerance to tissues.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-10-17	Buy	15636.00	HRT FINANCIAL LP
2023-11-13	Sale	-4702.00	Pankovcin Corinne
2023-11-13	Sale	-470.00	Nelson Charles Athle
2023-11-13	Sale	-470.00	Runge Jeffrey W.
2023-11-13	Sale	-470.00	Brady Brian Michael
2023-11-13	Sale	-4702.00	Farley Thomas J
2023-11-13	Sale	-4702.00	Albanna Rowena
2023-11-13	Sale	-9404.00	Albanna Amro A.
2023-11-13	Sale	-7053.00	Shabahang Shahrokh
2023-09-07	Sale	-20800.00	BNP PARIBAS SECURITIES CORP